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Executive Summary 
Addiction to medicines (ATM) is costly to individuals and the health care system, especially 
when there are limited tailored prevention and treatment interventions available and 
accessible to those who need them. Understanding how ATM is viewed and encountered by 
health professionals is likely to play an insightful role in furthering understanding of ATM as 
well as finding ways to prevent and treat ATM at a local and national level. The aim of this 
study was, therefore, twofold: (1) to investigate health professionals’ experiences of ATM 
and (2) their understanding of optimally identifying and addressing ATM.  
GP and pharmacy based staff from eight local authorities in Cheshire and Merseyside took 
part in the research by completing an online survey including multiple choice and open 
ended questions on the extent and nature of addiction to psychoactive medicines. In total, 
76 participants’ survey responses were analysed. Key findings included: 
Prevalence and nature of addiction 
 A large majority of participants (92%) agreed that ATM is an important health issue.
Participants indicated that they frequently suspected addiction with two thirds (66%)
reporting that they suspect a patient is developing an addiction on prescription only
medicines, and nearly half (46%) suspecting addiction to medicines purchased over
the counter, on a weekly or more frequent basis.
 It was identified that patients were most frequently developing addictions on
anxiolytics and hypnotics, as well as both strong and weak opioid analgesics. Less
frequently identified but still encountered addictions were drugs including anti-
epileptics and neuropathic analgesics, sedating antihistamines, antitussives and
stimulants.
Health professional responses to ATM 
 The majority of participants described feeling confident in: identifying ATM (76%),
speaking with suspected/affected patients (80%) and refusing medication (86%)
where necessary. Confidence was greater amongst pharmacy compared to GP staff.
Participants described several ways of identifying patients with ATM, such as noticing
early or frequent prescription requests, patients giving excuses of having lost
previous prescriptions and patients becoming aggressive when medication is not
available.
 In comparison to the frequency that addiction was identified, participants reported
taking action infrequently when they suspected a patient was developing ATM. A
number of barriers were identified to addressing ATM include; time pressures, feeling
unsure as how to talk about ATM, not wanting to adversely affect the patient’s other
health conditions, and having limited knowledge or ability to refer patients on to
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appropriate support services. It was recognised that denying patients their 
medication may be ineffective, especially as this could negatively affect patients’ 
wider health problems (e.g. chronic pain).  
Supporting addiction to medicine 
 Almost half (47%) of participants stated that current treatment options for ATM are 
not meeting patient need, especially for those patients who don’t identify themselves 
as having a drug-related problem. Some GP staff reported that taking more 
responsibility of patients with ATM was beyond their remit and resources. 
 Participants acknowledged several ways to improve identification and support offered 
to patients with ATM. These centred on offering more holistic modes of support (for 
example. therapeutic intervention not requiring medication, or a peer-mentoring 
service) and increasing access to specialised staff training and developing 
educational materials.  
Next Steps 
1. Establishing clear local treatment pathways that enable patients to access the 
support they need is required. It is beyond the scope of this study to make firm 
recommendations on what these treatment pathways should be, but a joined up 
approach to treatment for medicine addiction between front line health professionals, 
pain specialists and drug treatment providers with expertise in addiction is likely to 
benefit patients. In developing these pathways, it is important to recognise the 
diversity of the individuals affected by ATM and their routes to addiction problems. 
 
2. As part of developing an approach to treatment it will be useful to explore ways to 
support GP and pharmacy staff to identify and work with individuals with addiction to 
medicines, while acknowledging the limits of their resources. Health professionals 
who want to continue to support treatment of patients should be supported to do so 
and all health professionals should be easily able to refer patients to treatment.  
 
3. Create opportunities for health professionals to engage in specialised training that 
addresses how to not only identify patients with addiction to medicines, but also how 
to confidently tackle this issue, refuse medication where appropriate (and recognise 
where this may not be the best approach), provide tailored advice and refer them on 
to appropriate local services. It is important that where addiction is identified, health 
professionals have the resources to tackle this issue. 
 
4. More research is required in order to understand and address the needs of those 
individuals affected by ATM. Research into patient awareness and concern about 
addiction, motivations to seek support and barriers to seeking support is likely to be 
particularly useful. Evaluation of local treatment pathways in Cheshire and 
Merseyside will provide important examples of good practice and identify where there 
are particular treatment gaps.    
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Introduction 
Addiction to medicines (ATM) can be defined as the misuse of or dependence on 
prescription-only (POM) or over-the-counter (OTC) medicines [1]. Attention to and concerns 
around ATM has been growing since the 1980s [2]. A recent consultation concluded that the 
UK’s current clinical guidelines for drug misuse and dependence need to be updated and it 
is anticipated that a set of new guidelines will address significant changes in the sector 
which includes the increase in attention to ATM [3]. 
England’s drug strategy (2010) includes POM and OTC medicines in its ambition for tackling 
drug use and dependency [4]. In 2010, the Department of Health commissioned two reports 
to investigate the extent and nature of ATM and the effectiveness of current responses. The 
first report by the National Addiction Centre (NAC) consisted of a structured international 
literature review which aimed to provide evidence of the changing use of POM and OTC 
medicines [5]. The second carried out by the National Treatment Agency (NTA) investigated 
the configuration and commissioning of treatment services for ATM [1]. Neither report nor a 
further comprehensive literature review [6] from 2013, has been able to determine the extent 
and nature of ATM in England. However, all three claim that those who are misusing or 
dependent on POM or OTC medicines are considerably underrepresented at drug and 
alcohol treatment services. 
In 2013 national leadership for preventing and treating drug misuse (including ATM) was 
transferred from the NTA for Substance Misuse to Public Health England. While drug 
treatment services are acknowledged as having an important role in tackling ATM, there is 
an ultimate aim to enable individuals to become free from their dependence, to recover fully 
and live meaningful lives [7]. Public Health England and local authorities also highlight the 
requirement commissioners of these services have in understanding specific needs of 
different population groups [8]. The latest report in 2013 from the National Drug Treatment 
Monitoring System (NDTMS) tells us that the primary drug for which clients are seeking 
treatment for is opiates (47%) and opiates & crack (32%). Although just 886 of clients in the 
report were identified as approaching treatment for addiction to prescription medicines, this 
does not suggest that individuals with addiction to prescription medicines is an insignificant 
issue. Indeed, there may be a significant proportion of clients in the UK who experience 
addiction to prescription medicines yet fail to identify themselves with relevant treatment and 
support services. Furthermore, the report identified that 1,312 (1%) of clients were addicted 
to benzodiazepines [9]. As a related concern, the All Party Parliamentary Report claimed 
that there could be up to 1.5 million people dependent on benzodiazepines in the UK [10]. 
Trend data from the Office for National Statistics (ONS) also show that deaths involving 
benzodiazepines (as stated on a person’s death certificate), while not necessarily the 
primary cause of mortality, have almost doubled between 2006 and 2013 [11].  
It has been identified that those who are misusing or are dependent on OTC medicines are a 
‘hard to reach’ group [12]. For example, during 25 interviews with 12 males and 13 females 
aged 20- 60 attached to an online support group, it was recognised that participants did not 
see themselves as being the same as users of illicit drugs, often due to having stable jobs 
and a high level of education. Concurrently, most individuals felt personally responsible for 
their addiction and perceived current treatment options for ATM as being unsuitable for their 
particular needs. Individuals further reported going to great lengths to hide their problem and 
being apprehensive of seeking professional support, often due to anticipating stigma and 
having their addiction exposed to family, friend and colleagues. Additional barriers to 
accessing support, apart from lack of provision of specialised treatment services for ATM, 
included healthcare professionals’ own perceptions that ATM was a less severe issue 
compared to other addictions and that most individuals with ATM have the capacity to 
overcome it by themselves. However, this limited view disregards how ATM is a growing 
5 
 
problem and not all individuals affected may have the self-efficacy or resources to overcome 
it on their own. In light of these findings, greater awareness of the addiction potential of 
medicines is needed for both the public and health professionals, along with more 
specialised support services that can be effectively tailored and presented to potential users 
appropriately. Given the lack of empirical evidence on treatment programmes specific for 
ATM, more reviews of such interventions need to be undertaken, and ideally those involving 
both quantitative and qualitative methods in order to gain a deeper insight into what 
elements and mechanisms make them most or least effective.  
The NDTMS only collects data on those who are accessing treatment services [8]. The 
NTA’s 2011 review draws largely on NDTMS data and is therefore limited in its ability to 
capture data on the extent and characteristics of those who are addicted to POM or OTC 
medicines but not accessing services [1]. Similarly, the characteristics of those who are at 
risk of drug misuse as described in the Royal College of General Practitioners (RCGP) 
factsheet series are limited in their applicability, as most sources of evidence used derive 
from the US [13]. A qualitative study in the UK which looked at the experiences of those 
misusing OTC medicines found that most people had originally starting taking the medicine 
(which they later became addicted to) for genuine medical reasons rather than for 
experimentation [12]. PHE’s guidance on commissioning treatment for ATM claims within the 
pool of those who are misusing POM and OTC medicines, individuals may require different 
treatment responses as they have overlapping yet distinct explanations for their use. 
Explanations for use include, taking medicines, as: an alternative or supplement to illicit 
drugs; a commodity to sell; a way to relieve real or perceived physical or psychological 
symptoms; or a result of developing an iatrogenic addiction[8].   
NDTMS data trends can provide an indication as to which medicines are increasing in 
circulation nationally and locally. For instance, the NTA’s review highlights that NDTMS data 
shows clear regional differences in prescribing patterns, this includes the finding that for a 
number of years prescribing rates of benzodiazepines have been greatest in the north-west 
of England [1]. Analysis of electronic prescribing data (ePACT) also informs on prescribing 
patterns in primary care, for instance ePACT shows that between 2011 and 2013 prescribing 
rates for pregabalin and gabapentin have risen by 53% and 46% respectively [14]. Similarly, 
the Health and Social Care Information Centre (HSCIC) highlights that prescriptions for 
tramadol have increased by 29% over the last five years [15, 16], while the Office for 
National Statistics (ONS) reports an increase in deaths mentioning tramadol, since 1997 
[11]. By contrast, the long term trends for deaths mentioning paracetamol and other 
analgesics have been decreasing since 2004 [11].  
Cooper and colleagues argue that there is a need to raise awareness of the addiction 
potential of OTC medicines amongst medical prescribers, pharmacists and the public [12]. 
Currently in the UK there are a number of courses and resources (including e-learning) 
focusing on addiction to POM and OTC medicines, which provide further training and 
support to qualified GPs, Pharmacists and other healthcare professionals. These include 
those hosted by the Royal College of General Practitioners (RCGP) Substance Misuse and 
Associated Health (SMAH), the Centre for Pharmacy Postgraduate Education (CPPE) and 
Substance Misuse Management in General Practice (SMMGP).  
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This project 
This work was commissioned by the Cheshire and Merseyside Public Health (ChaMPs) 
Intelligence Network.  
The overall aim of the study was to investigate health professionals’ experiences around 
addiction to psychoactive medicines and to provide evidence on how best to support people 
with ATM in Cheshire and Merseyside. This included: 
 Examination of the frequency that health professionals encounter individuals with 
addictions to medicines 
 Identification of the current mechanisms by which health professionals identify 
addictions to medicines, and their experiences of tackling these 
 Identification of approaches to improve the identification and management of 
addictions to medicines 
 
Where possible, it was agreed that outcomes would be analysed by Local Authority area and 
place of work (within General practices or pharmacies). 
Methods 
An online survey was developed to be disseminated to staff based within GP services and 
pharmacies across Cheshire and Merseyside. All nine local authorities in Cheshire and 
Merseyside were invited to take part in the research, however Liverpool Local Authority 
chose not to take part. Within each authority, an individual was identified to lead 
dissemination of the survey in their area. The survey was sent to GP services and 
pharmacies in May 2015, and ran for six weeks.  
7 
 
Results 
 
In total 79 participants from GP practices and pharmacies submitted survey responses. 
Three participants were excluded due to providing insufficient amount of data, giving a total 
sample of 76. The characteristics of the sample are summarised in Table 11. Although 
Liverpool Local Authority chose not to take part in the investigation, two participants still 
identified themselves as working in this area. 
Table 1: Characteristics of the sample 
Local authority  
 
  
Years qualified  
 
 
Training regarding 
addiction to 
medicines 
 
Occupation 
setting  
 
 
Gender 
Response % Response  % Response  % Response % Response % 
Did not 
answer 
22 Did not 
answer 
21 Did not 
answer 
51 Did not 
answer 
21 Did not 
answer 
20 
S Helens 21 Less than 10 
years 
21 Specific 
course or 
training 
16 General 
Practice1 
50 Male 43 
Knowsley 20 Between 
10-19 years 
13 Self-study 
(e.g. online, 
conference) 
8 Pharmacy2 29 Female 37 
Sefton 17 Between 
20-29 years 
20 No specific 
training 
25     
Other3 20 over 30 
years 
25       
1 Included General Practitioner n=34, General Practitioner specialising in substance misuse n=1, Nurse Prescriber n=3 
2 Included Pharmacist n=19, Dispenser n=1, Pharmacy Technician n=2  
3 Other authority = Cheshire East (n=7), Liverpool (n=2), West Cheshire (n=1), Wirral (n=5) 
 
Extent of addiction to medicines 
Nearly all (92%, n=69/74) respondents strongly agreed or agreed that ATM is currently an 
important health issue. There was no differences between responses when analysed by 
demographic information. 
Participants were asked how frequently they suspect that patients2 are developing an 
addiction to POM and OTC medicines, and how frequently someone admits this to them. 
Participants indicated that they frequently suspected addiction with two thirds (66%, 48/73) 
reporting that they suspect a patient is developing an addiction on POM, and nearly half 
(46%, 31/68) suspecting addiction to OTC medicines, on a weekly or more frequent basis.  
                                                          
1 Some participants did not answer all questions in the survey, choosing to miss out some questions or not 
provide information about their place of work. Throughout this analysis, percentages presented relate to the 
number of participants who answered that question and not the overall sample. The number who answered 
the question which the finding refers to is provided. 
2 The term ‘patients’ is used as an all-encompassing term to include both patients and customers in the GP and 
pharmacy setting  
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Small proportions of the sample identified that patients admitted to them addiction to POM 
(12%, 9/75) and OTC medicines (11%, 8/70) on a weekly or more frequent basis. 
 
Figure 1: Frequency that participants suspect patients have 
an addiction to medicines (n=70) 
Figure 2: Frequency that patients admit to participants 
that they have an addiction to medicines (n=65) 
  
Pharmacy staff suspected more frequently that a patient is developing an addiction on 
medicines than GPs, however, there was no major difference in the number of patients seen 
admitting that they have an addiction to medicines (Figure 3).  
Figure 3: Frequency that participants suspect addiction to POM & OTC medicines and frequency that patients admit to 
participants that they have an addiction, by occupation of participant (n=60) 
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Participants also reported the frequency that they suspect a patient is developing an 
addiction on specific medicine groups (Figure 4). The groups where addiction was most 
frequently suspected included anxiolytics and hypnotics and both strong and weak opioid 
analgesics, where approximately 40% or more participants reported suspecting addiction on 
a weekly or more frequent basis. One quarter of participants reported suspecting addiction 
amongst patients on a weekly or more frequent basis to anti-epileptics and neuropathic 
analgesics, while addiction on other medicine groups was suspected on a less than monthly 
basis by the majority of participants. 
Figure 4: Frequency that participants suspect addiction amongst their patients, by medication group (n=70) 
 
 
Where participants indicated that they suspected addiction to a medication on a more 
frequent than monthly basis, they were asked to describe the characteristics of the patients 
that they suspected as having addiction to these medicines. For most medicines outlined, 
participants observed that addiction could cut across all ages and gender. ATM was noted to 
affect individuals who appeared ‘normal’, including those who were well-educated. It was 
also inferred that affected individuals are likely to have current or past issues related to 
substance abuse, and/or negative life circumstances/ trauma that make them particularly 
vulnerable to ATM. Nevertheless, certain populations groups were suspected as being 
addicted to some medicines more than others. Classifications of drugs and relevant 
examples provided in participants’ responses are shown in Appendix A.  
Anxiolytics/ hypnotics (n= 55) 
Both health professional groups suspected addiction to mainly affect middle-aged males and 
older females (e.g. usually over >65), as well as individuals experiencing chronic pain and 
poor mental health, such as depression and anxiety. Pharmacy staff additionally observed 
that teenage males also used them to seek pleasure or pain relief.  
Strong opioid analgesics (n= 36) 
Participants reported suspecting middle aged individuals and those presenting with chronic 
pain, including fibromyalgia in females and back pain for males, of misuse of strong opioid 
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analgesics. Pharmacy staff further suggested that addiction was commonly suspected 
amongst young men who were also addicted to illegal substances. 
Weak analgesics (n= 44) 
While GP’s suspected addiction to weak opioid analgesics to affect 25-55 year olds, notably 
individuals with depression, poor mental health or history of abuse and/or imprisonment, 
pharmacy staff mainly suspected such an addiction in males aged between 20-30 or females 
aged 30-40.  
Anti-epileptics/anticonvulsants and neuropathic analgesics (n= 22) 
GP staff mainly described individuals with suspected addiction to these medicines as having 
chronic pain, depression, anxiety and past experience of substance misuse. Pharmacy staff 
observed that suspected individuals tended to be those making subjective complaints like 
nerve pain or as having experienced life trauma or an accident (e.g. a car accident).   
Antitussives (n= 4) 
GP staff regarded individuals addicted to antitussives as more likely to be middle-aged drug 
users and/or individuals out of prison. Suspicion was also more common among females 
with chronic pain. Pharmacy staff on the other hand tended to suspect addiction to 
antitussives across a wide range of individuals. 
Stimulants (n= 7) 
Patients suspected of being addicted to stimulants were more likely to be young people who 
were seeking pleasure and engaging in risky behaviour. Misuse was suspected as most 
predominant amongst young males with concurrent use of street drugs and/or history of 
alcohol abuse.  
Sedating antihistamines (n=11) 
Participants described suspecting middle aged and older individuals with sleeping problems 
as being addicted to sedating antihistamines (e.g. diphenhydramine). In particular, such 
individuals were identified as likely to be having problems relating to disruptive shift-working 
patterns and appearing visibly unhealthy (e.g. overweight or obese).   
Other medications  
Participants were asked to list other medications, including those of a non-psychoactive 
nature, which they were concerned about. For GP staff, additional substances that were 
suspected as causing problems with addiction included pregabalin, tramadol, co-codamol, 
cyclizine and TCA, as well as non-psychoactive drugs such as orlistat (used in weight 
management) and laxatives. Pharmacy staff further reported cyclizine, antidepressants, 
paracetamol, neurofen plus (Ibuprofen and codeine), ibuprofen and aspirin as a concern. 
Pharmacy staff also frequently referred to laxatives as being a common concern that was 
not being adequately addressed.  
Identification of addiction to medicine 
Some participants (n=60) reported scenarios that alerted them as to whether their patients 
might be addicted to medicines, including:  
- Frequent, and often early, prescription requests for potentially addictive medications, 
notably in their strongest forms at higher dosages (n=56) 
- Patients displaying certain emotional and behavioural characteristics, such as 
appearing anxious, frustrated or aggressive when their medication was unavailable 
or not on time (n=20) 
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- When patients gave excuses, notably of having ‘lost’ their previous prescription 
(n=12)  
- Repeated requests for potentially addictive medication despite not responding to 
treatment or having no actual diagnosis by a medical professional (n=9) 
- Patients acting in a suspicious manner and poor ability to interact with staff (n=7) 
- Reluctance from patients to change or reduce their medication (n=4).  
- Patients frequently checking whether medication was ready (n=4) 
- Patients having an unhealthy or neglected appearance (n=3). 
- Referring to medication as an urgent “need” (n=3) 
- Going to different pharmacies/doctors for medication  (n=3) 
- Patients knowing the price of certain over the counter medicines without asking 
(n=2). 
 
Confidence identifying addiction 
Over three quarters of participants felt ‘very’ or ‘fairly’ confident in identifying individuals who 
are developing an addiction (76%, n= 47/62), initiating a conversation (80%, n=50/63) about 
this and refusing access (86%, n=54/63) to medicines where appropriate, with small 
proportions indicating that they did not feel confident in these areas. Figure 5 provides a 
breakdown of these responses. 
GP staff who felt either ‘very’ or ‘fairly’ confident were often those who had received 
specialised training, and had several years’ experience addressing needs of addicted 
patients. Confidence levels depended on the characteristics of the patient and how well GPs 
knew them, alongside patients’ willingness to discuss the topic of addiction. Factors that 
limited GP’s confidence included pressure to meet many other patients’ needs in a short 
space of time. Pharmacy staff identifying as ‘very’ or ‘fairly’ confident perceived themselves 
as having a role in helping service users. However, confidence was marred by feeling 
unable to refer service users to specialised forms of support, which was seen to be the 
responsibility of GPs and specialised drug services.   
Participants who didn’t feel confident (those identifying themselves as not confident or 
unsure about their level of confidence) often described fearing that the individual might 
become aggressive. This limited confidence in terms of communicating effectively with 
individuals suspected of addiction and providing them with support. GPs with low confidence 
feared that they would be blamed for providing inaccurate or unhelpful advice, while 
pharmacy staff lacking in confidence perceived that customers would simply purchase 
medication from other pharmacies if issues surrounding ATM were raised with them.  
Furthermore, pharmacy staff described that their confidence is reduced by the fact that they 
are not able to help service users with their wider health concerns. For example, some 
professionals emphasised that helping patients effectively requires additional support with 
their mental health problems and negative life-circumstances – which may be beyond the 
remit of their current expertise or require other services/resources that were inaccessible to 
them.  
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Table 2: Confidence identifying addiction 
 GP (n=38) 
n (%) 
Pharmacy (n=22) 
n (%) 
Very confident 4 (11) 4 (18) 
Fairly confident 25 (66) 13 (59) 
Unsure 4 (11) 2 (9) 
Slightly confident 3 (8) 0 
Not confident 2 (5) 3 (14) 
 
Responding to addiction to medicines 
Participants were asked how confident they felt i) initiating a conversation with individuals 
they suspected were developing an addiction and ii) refusing access to medication (Figure 
5). 
Responses from GP and pharmacy-based staff were similar although pharmacy-based staff 
were less likely to report being confident in initiating conversations where they suspected 
addiction (Table 3). There was evidence that a minority of both GP and pharmacy-based 
staff do not feel confident taking action when they identify an addiction (Table 4). 
 
Figure 5: Level of confidence identifying addiction to medicine and taking action about addiction (n=70) 
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Table 3: Confidence initiating conversations around addiction to medicine 
 GP-based (n=38) 
n (%) 
Pharmacy based (n=22) 
n (%) 
Very confident 8 (21) 2 (9) 
Fairly confident 19 (50) 8 (36) 
Unsure 1 (3) 4 (18) 
Slightly confident 5 (13) 6 (27) 
Not confident 5 (13) 1 (5) 
Not applicable 0 1 (5) 
 
Table 4: Confidence refusing medication to those addicted to medicine 
 GP-based (n=38) 
n (%) 
Pharmacy based (n=22) 
n (%) 
Very confident 9 (24) 7 (32) 
Fairly confident 15 (39) 10 (45) 
Unsure 3 (8) 1 (5) 
Slightly confident 7 (18) 3 (14) 
Not confident 4 (11) 1 (5) 
 
Participants were asked to describe how frequently they took action when they suspected an 
addiction, including i) initiating a conversation with a patient and ii) refusing access to 
medication. A substantial proportion of participants reported taking action against suspected 
addiction only very occasionally. In total, 43% (27/63) reported that they initiate a 
conversation with or refuse medication to someone who they suspect of developing an 
addiction every six months or less frequently. Of the remainder of the sample a small 
proportion (17%, 11/ 63) reported initiating a conversation 2-4 times a week or more 
frequently, and one quarter (25%, 16/63) reported refusing access to medication 2-4 times a 
week or more frequently. 
 
The regularity in which GP and pharmacy-based staff initiated conversations and refused 
access to medication were similar. However, a comparison of the regularity of which 
addiction was suspected, particularly amongst pharmacy-based staff and the reported 
frequency that action was taken suggests that intervention is far less frequent (Figure 6) 
than might be expected.  
 
Figure 6: Frequency that action is taken by participants alongside participant suspicion of addiction amongst patients 
(n=63) 
 
0
20
40
60
80
100
Suspected
addiction
Initiated
conversation
Refused
access
Suspected
addiction
Initiated
conversation
Refused
access
GP Pharmacy
%
Weekly or more Monthly or more Less than monthly
14 
 
 
Supporting individuals with addiction to medicines 
Treatment options 
Almost half (47%, 29/61) of participants felt that current treatment pathways are not meeting 
the needs of those who have addiction to medicines. GP staff (66% 25/38) were much more 
likely to indicate that current treatment pathways are not meeting patient needs than 
pharmacy staff (18%, 4/22). 
Current levels of intervention and support 
Participants typically described a perception of inadequate, limited or no provision of 
appropriate support services and were often unsure about specific referral pathway 
availability. This perceived lack of support was seen as inequitable compared to support 
services for individuals addicted to illicit drugs such as heroin and cocaine. There were also 
concerns among some pharmacy staff that simply restricting or denying medicines to 
patients with ATM was not a straightforward decision for them to make. More specifically, 
without recommendations from a patient’s GP, they were unsure about making a decision 
that might have negative implications on treatment of the patient’s health condition, such as 
chronic pain.  
Improving support to individuals with ATM and reducing harm 
In order to help support individuals with ATM, several GP and pharmacy staff (n=36) made 
suggestions to:  
 
- Increase awareness of ATM, which might include displaying educational leaflets and 
posters in waiting rooms, encouraging individuals to be more open about their 
addiction to health professionals, family and friends (n=6). 
- Develop more support services, i.e. with dedicated resources for populations with 
ATM (n=4).  
- Better awareness and use of referral systems between GPs, pharmacies and support 
services (n=3) 
- Reduce stigma associated with ATM (n=2) 
- Restrict dispensing of OTC medications, or time limited prescriptions from GP, so 
that repeat prescriptions cannot be made too frequently (n=2) 
- Provide more visible warning labels on medicines that have addictive potential (n=2) 
- Establish a peer-mentoring support group, ideally made up of individuals with a 
similar demographic to those with an addiction to medicine (n=2).  
 
Support for and role of health professionals 
Responsibility and role   
More than half of participants (59%, n = 35/59) said they would not like to have a role 
supporting individuals with addiction to medicines. When looking at the difference between 
staff based within pharmacies and GPs (n=58), the majority of pharmacy staff (70%, 
n=14/20) said they would like a role, while the majority (76%, n=29/38) of GP staff said they 
would not. When asked about training on the topic, only a small number of GPs and 
pharmacy staff (16%, 6/38) wanted to be provided with specialised training or advice. This 
was described as being to increase their confidence and/or gain greater job satisfaction 
through helping others. Some GPs (50%, 9/18) and pharmacy staff (27%, 3/11) referred to 
being unwilling or unable to provide additional support as they anticipated that it would lead 
to more time pressures and demands.  
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Improving identification of individuals with ATM 
Including both GP and pharmacy staff (n=45), when asked about ways that they could 
improve identification of patients with ATM, some suggestions included to:  
- Increase access for healthcare staff to specialised training and education materials 
so that staff can provide evidence-based advice (n=8) 
- Provide more time and opportunities for communication and joint working between 
GPs, pharmacies and other health services to aid rapid identification of addiction and 
support (n=6) 
- Offer a greater diversity of tailored non-medication options to address individuals’ 
unique needs more holistically, including specialised referral pathways for addiction, 
pain clinics and counselling (n=5).  
- Creating suitable media campaigns to raise awareness about addiction to medicines 
(n=4).  
- Develop a computer programme or screening tool that can identify individuals at risk 
of ATM and/or monitor prescriptions and/or OTC medicine purchasing so as to raise 
an alarm when they are being used to frequently (n=4) 
Support with refusing medication to individuals with ATM  
In order to confidently refuse medication to individuals with ATM, some GP and pharmacy 
staff (n=30) stated that they may require: 
- Information about a service they can offer as an alternative to medication (e.g. being 
able to offer psychosocial or holistic forms of therapy) (n=24).  
- Training on how to effectively communicate with individuals with ATM , as well as 
policies and procedures that allow patients/customers to be dealt with appropriately 
(n=4) 
- A physical barrier on the pharmacy counter or support in the pharmacy in order to 
avoid harassment of staff (n=2).  
Local Authority Differences 
Local Authority information was available for 59 (78%) of participants. While it was intended 
to breakdown results where appropriate by each Local Authority, findings are presented here 
for participants from St Helens (n=16), Knowsley (n=15) and Sefton (n=13). For the 
remaining local authorities, participant numbers were low (n=15) and participants have been 
grouped together as ‘other’ local authority in this analysis. Proportions of GP and pharmacy 
based staff responding to the survey were similar across local authorities. 
 
Extent of addiction to medicines 
There were some differences in the extent of addiction by local authority. Differences 
included that participants based in Knowsley reported encountering addiction to POM and 
OTC more frequently, and in Sefton less frequently, than those within other local authorities. 
It is important to note that it was not possible to determine from this data whether these 
findings are due to there being a higher prevalence of addiction to medicines in some local 
authorities than others, or other factors (for example the rate that addiction is identified or 
the comparative response rate for that area). 
 
Confidence and action in tackling addiction 
Participants in Sefton reported taking action, including initiating conversations about 
addiction and refusing medication, less frequently than those in other local authorities. 
Participants in Knowsley appeared slightly less confident in identifying possible addiction, 
initiating conversations and refusing medication than those in other local authorities. While 
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there were some small differences between other local authorities on these measures, 
patterns of taking action were generally similar. 
 
Experiences of training 
Across the local authorities, between one half and two thirds of participants reported that 
they had received specific training or undertaken self-learning regarding addiction to 
medicines. In Sefton only one out of eight participants reported having undertaken training. 
 
Discussion 
The present study’s findings are relevant to Cheshire and Merseyside, while supporting 
current evidence on a wider scale that addresses ATM as a significant public health 
issue [8, 17]. For example, some studies have similarly reported that the majority of 
professionals responding to surveys were concerned that ATM was regularly occurring 
in their practice while listing several OTC and POM being obtained for misuse. 
However, findings here additionally suggest that identification and observation of 
individuals with ATM does not positively correspond with the relatively small proportion 
of professionals taking action to help their patients – the majority of whom are not 
currently accessing appropriate support and treatment [6, 12]. The provision of support 
for individuals addicted to medicines was presented as being inadequate compared to 
individuals affected by addiction to illicit drugs, supporting previous qualitative findings 
that show treatment for ATM as being ineffective and not specialised enough [6, 18].  
What medicines are misused and which populations are affected? 
In line with previous studies, the most frequently suspected addictions in our study 
mainly included anxiolytics and hypnotics (e.g. benzodiazepines and z-drugs), strong 
and weak opioid analgesics and anti-epileptics/ neuropathic analgesics. In line with 
current evidence the most commonly abused substances were often regarded as those 
containing codeine [5, 18, 19]. This supports research highlighting that the risk of 
becoming addicted to medicines containing codeine (formulated with other analgesics 
such as paracetamol, ibuprofen, and aspirin), resulting in subsequent adverse effects 
(e.g. gastrointestinal haemorrhage, nephrotoxicity and overdose), is high where access 
to codeine is less regulated [20]. 
Some professionals in this study further highlighted the issue that some of their patients 
are purchasing excessive quantities of laxatives and weight loss medications, which 
has been acknowledged in other investigations [6, 12, 18, 21, 22]. While this study 
focussed on psychoactive medicines, tackling abuse of laxatives and weight loss 
medicines is important, as recurrent use and/or addiction to these substances can have 
several costly and harmful implications, especially among individuals with an eating 
disorder [23, 24]. 
In the present study both GP and pharmacy staff identified that ATM is suspected in a 
diversity of individuals. While this is in line with previous research [6, 12, 18], findings 
here go on to suggest that specific groups are more likely to be suspected of addiction 
to certain medicines than others. For example, again supporting current evidence on 
those with ATM, professionals described that middle aged women and men, more so 
than young people, seek potentially addictive medicines for chronic pain (e.g. 
Fibromyalgia) [25] and sleep problems [26]; which can leave them more at risk of 
becoming addicted to analgesics, hypnotics and sedating antihistamines. Although 
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trends in prescribing of these types of medicines have been decreasing within the UK 
over the last several years, they still make up a large proportion of the medicines to 
which individuals are addicted [1, 27].  
Young people were regarded by professionals in this study as being particularly 
vulnerable to ATM. This might be due to the greater likelihood of risky behaviour among 
young people (notably with their peer groups) and use of maladaptive coping strategies 
for stress, anxiety and depression when transitioning to adulthood and/or when 
experiencing demands of intensive study [28]. For example, analgesics like 
paracetamol are commonly abused drugs among young people in both the UK and 
USA, including high school and university students [29, 30]. Authors of a recent USA 
study also pointed out that around 18% of young adults between 18-25 have at some 
point intentionally misused OTC or POM [31]. Furthermore, excessive alcohol 
consumption has been positively associated with addiction to prescription drugs, 
including in young people [32, 33]. 
Other specific populations identified in this study as potentially at risk of ATM included 
former prisoners. This aligns with previous research findings showing that prisoners 
often abuse OTC or POM, partly due to encountering more adverse life experiences 
and health problems related to anxiety, pain and poor sleep than the general population 
[34]. Professionals additionally commented on how adverse childhood experiences, life 
trauma or having current issues and/or past experiences of addiction could contribute to 
becoming at risk of ATM. This reflects national trends in the UK, with 10% of service 
users in treatment for ATM having been identified as experiencing comorbid illicit drug 
problems [1]. Furthermore, prevalence of ATM among users of illicit drugs (18%) is 
estimated to be nearly three times higher than the general population not using illicit 
drugs (5%) [35]. 
In most cases, ATM is reported to develop from initially taking medication as part of a 
health improvement practice (e.g. recommended treatment regime from a GP or family 
member), as opposed to seeking hedonic pleasure [6, 36]. However, to date, there is 
limited/no evidence to address what specific proportion of individuals with ATM have an 
initial intention to misuse a certain medicine as compared to seeking support for an 
existing health concern. Nevertheless, taking action on ATM is likely to require 
intervention at the point where GPs and pharmacists feel better able to offer non-
medicine alternatives or provide smaller quantities of potentially addictive medicines to 
their patients. This has already been partially tackled through the reductions in the 
maximum pack sizes for codeine-containing medicines put into place in 20093. 
Identifying and approaching individuals with ATM 
Professionals were often confident in being able to identify service users with ATM. For 
example, typical means of identification involved acknowledging when patients were 
continuing to take large doses of medication despite not responding to treatment. They were 
also aware of patients acting in a suspicious manner, and when they obtained medication 
from different pharmacies – behaviours that have been identified as common among 
individuals with ATM [37]. However, findings in the present study suggested that many 
professionals, especially pharmacy staff, were not confident raising their concerns with 
patients. Consequently, while patients in need might be easily identified as having an ATM, 
gaining support for their problem will remain an issue unless GP and pharmacy staff are able 
to feel more confident when approaching patients, discussing their concerns, and informing 
them of ways they can gain access to appropriate support. Yet while this study’s findings 
                                                          
3 http://www.chemistanddruggist.co.uk/content/rpsgb-law-and-ethics-bulletin-otc-codeine-dihydrocodeine  
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imply that there are several practical ways of improving support of individuals with ATM, 
there may be several barriers when trying to do so. As also identified in current findings, 
professionals may need to have access to more time and resources in order to feel willing 
and capable of assisting patients with ATM.  
Barriers to supporting individuals with ATM 
This study noted professionals’ negative views around specific barriers faced when 
providing support. In particular, individuals affected by ATM may not typically identify 
themselves as ‘drug addicts’ (e.g. illicit drug users) and, as acknowledged in the current 
findings and elsewhere, may be unwilling to openly speak about their concerns to 
professionals, especially pharmacy staff [6, 12, 18]. This may be due to individuals 
requiring greater time to develop rapport and understanding with GP staff, preferably 
those they already feel familiar with. However, unwillingness to speak openly about 
concerns might also be due to the negative stigma attached to identifying oneself as a 
drug addict. This stigma may be more marked among individuals who perceive 
themselves as having a high degree of education and/or intelligence [38], which appear 
to be well represented among populations addicted to medicines. With these barriers to 
disclosing problems around ATM, affected individuals have been shown to prefer 
accessing online support groups where their addiction feels more accepted, understood 
and less-stigmatised [6, 12]. However, it is important to note that such online support 
groups will not be universally effective and a number of individuals are likely to be under 
supported by the current health and social care provision. For example, a recent study 
found that online support groups for drug sobriety was not as effective as face-to-face 
meetings as part of a 12-step recovery program4. 
It is important that actions to improve support for individuals with ATM involves 
increasing professionals’ confidence to tackle these issues. For example, findings in 
this study and elsewhere suggest that professionals should be provided with more 
opportunities for specialised training. It is recognised that support services for those 
with ATM are limited and where these exist they may be perceived as lacking and 
inequitable compared to support available for individuals addicted to illicit drugs. Where 
current treatment options are viewed as poor, this might further diminish professionals’ 
confidence when deciding whether to initiate a supporting conversation with their 
patients or refer them to support services.  
The provision of treatment for people addicted to medication varies throughout the UK, 
with a greater proportion of such individuals being located in the North of England. For 
example, compared to the national average of 16% of individuals being treated for drug 
addiction having an ATM, this figure rises to 18% in the North West and further to 27% 
in the North East [1].  Decisions regarding the commissioning of treatment are 
complicated, and take into account the limited resources available, and pressures that 
promoting service availability to this population will place on treatment services. If 
numbers of individuals with ATM continue to rise, this will likely place a strain on both 
national and local community resources. 
  
                                                          
4Drug Free. (2015). Accessed on 2nd October 2015 at: http://www.drugfree.org/join-together/study-online-
support-groups-effective-face-face-meetings-sobriety/  
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Next Steps 
 
1. Establishing clear local treatment pathways that enable patients to access the 
support they need is required. It is beyond the scope of this study to make firm 
recommendations on what these treatment pathways should be, but a joined up 
approach to treatment for medicine addiction between front line health professionals, 
pain specialists and drug treatment providers with expertise in addiction is likely to 
benefit patients. In developing these pathways, it is important to recognise the 
diversity of the individuals affected by ATM and their routes to addiction problems. 
 
2. As part of developing an approach to treatment it will be useful to explore ways to 
support GP and pharmacy staff to identify and work with individuals with addiction to 
medicines, while acknowledging the limits of their resources. Health professionals 
who want to continue to support treatment of patients should be supported to do so 
and all health professionals should be easily able to refer patients to treatment.  
 
3. Create opportunities for health professionals to engage in specialised training that 
addresses how to not only identify patients with addiction to medicines, but also how 
to confidently tackle this issue, refuse medication where appropriate (and recognise 
where this may not be the best approach), provide tailored advice and refer them on 
to appropriate local services. It is important that where addiction is identified, health 
professionals have the resources to tackle this issue. 
 
4. More research is required in order to understand and address the needs of those 
individuals affected by ATM. Research into patient awareness and concern about 
addiction, motivations to seek support and barriers to seeking support is likely to be 
particularly useful. Evaluation of local treatment pathways in Cheshire and 
Merseyside will provide important examples of good practice and identify where there 
are particular treatment gaps.    
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Appendix A: Drug classifications and examples 
Drug Classification 
 
Examples  
Anxiolytics and hypnotics Benzodiazepines e.g. Chlordiazepoxide, Diazepam, 
Loprazolam, Lorazepam, Nitrazepam, Oxazepam, 
Temazepam, Clonazepam 
 
Z-drugs e.g. Zaleplon, Zolpidem, Zopiclone 
 
Strong opioid analgesics Pethidine, Methadone, Oxycodone, Opium tincture, 
Anhydrous morphine, Kaolin and Morphine 
 
Weak opioid analgesics Codeine, Dihydrocodeine, Tramadol 
 
Anti-epileptics and neuropathic 
analgesics 
Pregabalin, Gabapentin, Carbamazepine 
 
Antitussives 
 
Dextromethorphan, pholcodeine, codeine linctus 
 
Stimulants 
e.g. Methylphenidate, 
Dexamfetamine, Modafinil, 
Pseudoephedrine 
 
Methylphenidate, Dexamfetamine, Modafinil, 
Pseudoephedrine 
 
Sedating antihistamines 
 
Promethazine and diphenhydramine 
 
Adapted from: Public Health England 2013: Commissioning treatment for dependence on prescription and over-the-counter 
medicines: a guide for NHS and local authority commissioners. Appendix A. Some medicines liable to misuse or dependence. 

